Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000222492 | SCV000270062 | likely benign | not specified | 2015-06-24 | criteria provided, single submitter | clinical testing | p.Asn258Ser in exon 5 of CHRM2: This variant is not expected to have clinical si gnificance because of its population frequency and lack of evolutionary conserva tion. It is present in 0.2% (135/66208) of European chromosomes screened by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs1420 06633). Two mammals and >10 bird, reptile and fish species carrying a serine (Se r) at position 258, supporting that this change may be tolerated. |
Gene |
RCV000222492 | SCV000531706 | benign | not specified | 2018-02-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000543439 | SCV000659700 | benign | Dilated Cardiomyopathy, Dominant | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004705045 | SCV005226804 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003929885 | SCV004745871 | likely benign | CHRM2-related disorder | 2021-04-07 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |